Wai Choi

Statistics

Publications

Citations

534

H-Index

Active since

2002

Affiliations

Infectious Disease Research Institute(Current)

Colorado State University

University of California, Los Angeles

Texas A&M University

GlaxoSmithKline (Spain)

Wai Choi is an author at Infectious Disease Research Institute specializing in enzyme inhibition, pharmacology, and mycobacterium tuberculosis infection.

Publications per year

2002–2019

Publications

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)

Xianfeng Li, Vincent Hernandez, Fernando Rock et al. · Journal of Medicinal Chemistry · 2017 · 162 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Andrés Palencia, Xianfeng Li, Wei Bu et al. · Antimicrobial Agents and Chemotherapy · 2016 · 121 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

TFIIH XPB mutants suggest a unified bacterial-like mechanism for promoter opening but not escape

Yin C. Lin, Wai Choi, Jay D. Gralla · Nature Structural & Molecular Biology · 2005 · 79 citations

Life Sciences, Genetics, Molecular Biology +15

Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase

Ebere Sonoiki, Andrés Palencia, Denghui Guo et al. · Antimicrobial Agents and Chemotherapy · 2016 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of a cofactor-independent inhibitor ofMycobacterium tuberculosisInhA

Yi Xia, Yasheen Zhou, David S. Carter et al. · Life Science Alliance · 2018 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 8